Business Description
![Quince Therapeutics Inc Quince Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BMAY.png?14)
Quince Therapeutics Inc
NAICS : 325412
SIC : 2836
ISIN : US22053A1079
Description
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.81 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.5 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 35.6 | |||||
3-Year EPS without NRI Growth Rate | 37.6 | |||||
3-Year FCF Growth Rate | 34.2 | |||||
3-Year Book Growth Rate | -30.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.31 | |||||
9-Day RSI | 50.87 | |||||
14-Day RSI | 49.37 | |||||
6-1 Month Momentum % | -48.18 | |||||
12-1 Month Momentum % | -56.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.16 | |||||
Quick Ratio | 7.16 | |||||
Cash Ratio | 6.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.3 | |||||
Shareholder Yield % | -20.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -36.09 | |||||
ROA % | -25.46 | |||||
ROIC % | -78.99 | |||||
ROC (Joel Greenblatt) % | -8082.82 | |||||
ROCE % | -25.26 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.44 | |||||
EV-to-EBIT | 0.74 | |||||
EV-to-Forward-EBIT | -0.01 | |||||
EV-to-EBITDA | 0.75 | |||||
EV-to-Forward-EBITDA | -0.01 | |||||
EV-to-FCF | 0.92 | |||||
Earnings Yield (Greenblatt) % | 135.14 | |||||
FCF Yield % | -71.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QNCX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quince Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.76 | ||
Beta | 1.22 | ||
Volatility % | 50.13 | ||
14-Day RSI | 49.37 | ||
14-Day ATR ($) | 0.056966 | ||
20-Day SMA ($) | 0.72393 | ||
12-1 Month Momentum % | -56.44 | ||
52-Week Range ($) | 0.6331 - 1.67 | ||
Shares Outstanding (Mil) | 43.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quince Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quince Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Quince Therapeutics Inc Frequently Asked Questions
What is Quince Therapeutics Inc(QNCX)'s stock price today?
The current price of QNCX is $0.75. The 52 week high of QNCX is $1.67 and 52 week low is $0.63.
When is next earnings date of Quince Therapeutics Inc(QNCX)?
The next earnings date of Quince Therapeutics Inc(QNCX) is 2024-08-02 Est..
Does Quince Therapeutics Inc(QNCX) pay dividends? If so, how much?
Quince Therapeutics Inc(QNCX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |